Jiangsu Aidea Pharmaceutical Co., Ltd.
public_traded
Jiangsu Aidea Pharmaceutical Co., Ltd. is publicly traded on SHH under ticker 688488.SS.
Jiangsu Aidea Pharmaceutical Co., Ltd. develops, produces, and sells pharmaceutical products. It offers folium sennae granules, powdered bacillus tablets, clindamycin hydrochloride capsules, sodium bicarbonate tablets, nitrendipine tablets, metronidazole tablets, compound gentamycin sulfate and procaine hydrochloride sulfate granules, and cefradine capsules, as well as raw materials. The company was founded in 2009 and is based in Yangzhou, China.